SCHEMBL21495082

SCHEMBL21495082

COc1ccc(COC(=O)Nc2nccs2)cc1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.63
NPC1 O15118 3/20 0.63
PKM P14618 2/20 0.63
LMNA P02545 3/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
TP53 P04637 2/20 0.61
TSHR P16473 1/20 0.61
GAA P10253 2/20 0.59
MGAM O43451 1/20 0.59
SI P14410 1/20 0.59
MGAM2 Q2M2H8 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
ALDH1A1 P00352 2/20 0.54
PTGS2 P35354 1/20 0.54
MAPK1 P28482 1/20 0.52
KCNA5 P22460 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
POLB P06746 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL747058 0.84 KDM4E (0.60) RAB9ANPC1PKMLMNASMN1; SMN2
SCHEMBL3409592 0.77 NPC1 (1.00) RAB9ANPC1PKMLMNASMN1; SMN2
SCHEMBL28478360 0.77 RAB9A (1.00) RAB9ANPC1PKMLMNASMN1; SMN2
Hydrochloric Acid SCHEMBL11314938 0.77 RAB9A (0.66) RAB9ANPC1PKMLMNASMN1; SMN2
SCHEMBL13550297 0.76 NPC1 (0.61) RAB9ANPC1PKMLMNASMN1; SMN2
SCHEMBL8366793 0.76 PKM (0.74) RAB9ANPC1PKMLMNASMN1; SMN2
SCHEMBL628283 0.75 L3MBTL1 (0.62) RAB9ANPC1PKMLMNASMN1; SMN2
SCHEMBL2379769 0.74 NPC1 (0.56) RAB9ANPC1PKMLMNASMN1; SMN2
SCHEMBL10809546 0.74 L3MBTL1 (1.00) RAB9ANPC1PKMLMNASMN1; SMN2
SCHEMBL21495032 0.74 LIMK1 (0.55) RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584742-B2 Substituted aminothiazoles as inhibitors of nucleases MASARYKOVA UNIVERZITA (CZ) 2023-02-21 US disclosed
US-20220002282-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2022-01-06 US disclosed
WO-2019201865-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2019-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11584742-B2 Substituted aminothiazoles as inhibitors of nucleases RNASEH1, DNASE1, FEN1 RAB9A 2879/4885NPC1 3091/4885PKM 3484/4885
US-20220002282-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES RNASEH1, DNASE1, FEN1 RAB9A 2879/4885NPC1 3091/4885PKM 3484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.